File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0168-8278(03)80489-0
- WOS: WOS:000182174500072
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: A phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV
| Title | A phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV |
|---|---|
| Authors | |
| Issue Date | 2003 |
| Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep |
| Citation | The 38th Annual meeting of the European Association for the study of the liver, Istanbul, Turkey, 29 March - 1 April 2003. In Journal of Hepatology, v. 38 n. suppl. 2, p. 27, abstract no. 73 How to Cite? |
| Description | Abstract |
| Persistent Identifier | http://hdl.handle.net/10722/225159 |
| ISSN | 2023 Impact Factor: 26.8 2023 SCImago Journal Rankings: 9.857 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marcellin, P | - |
| dc.contributor.author | Lau, GKK | - |
| dc.contributor.author | Mommeja-Marin, H | - |
| dc.contributor.author | Sacks, S | - |
| dc.contributor.author | Sereni, D | - |
| dc.contributor.author | Bronowicki, JP | - |
| dc.contributor.author | Conway, B | - |
| dc.contributor.author | Trepo, C | - |
| dc.contributor.author | Mondou, E | - |
| dc.contributor.author | Snow, A | - |
| dc.contributor.author | Yoo, BC | - |
| dc.contributor.author | Lee, HS | - |
| dc.contributor.author | Rousseau, F | - |
| dc.date.accessioned | 2016-04-26T02:56:58Z | - |
| dc.date.available | 2016-04-26T02:56:58Z | - |
| dc.date.issued | 2003 | - |
| dc.identifier.citation | The 38th Annual meeting of the European Association for the study of the liver, Istanbul, Turkey, 29 March - 1 April 2003. In Journal of Hepatology, v. 38 n. suppl. 2, p. 27, abstract no. 73 | - |
| dc.identifier.issn | 0168-8278 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/225159 | - |
| dc.description | Abstract | - |
| dc.language | eng | - |
| dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep | - |
| dc.relation.ispartof | Journal of Hepatology | - |
| dc.rights | Posting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
| dc.title | A phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Lau, GKK: gkklau@netvigator.com | - |
| dc.identifier.doi | 10.1016/S0168-8278(03)80489-0 | - |
| dc.identifier.hkuros | 83517 | - |
| dc.identifier.volume | 38 | - |
| dc.identifier.issue | suppl. 2 | - |
| dc.identifier.spage | 27, abstract no. 73 | - |
| dc.identifier.epage | 27, abstract no. 73 | - |
| dc.identifier.isi | WOS:000182174500072 | - |
| dc.publisher.place | Netherlands | - |
| dc.identifier.issnl | 0168-8278 | - |